Zobrazeno 1 - 10
of 18
pro vyhledávání: '"E. A. Kurnikova"'
Autor:
L. I. Papusha, D. N. Balashov, A. N. Tul'pakov, E. V. Skorobogatova, E. E. Kurnikova, Y. V. Skvortsova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 61-69 (2022)
Various conditioning regimes influence on sexual development and gonads function in children and adolescent after stem cell transplantation was studied. 45 patients were enrolled in the study: 23 patients with aplastic anemia (АА), who received non
Externí odkaz:
https://doaj.org/article/72db1aeb390c4972b33b7e6ded0db106
Autor:
Y. V. Skvortsova, D. N. Balashov, Y. Y. Djakonova, Z. M. Dishlevaya, E. E. Kurnikova, N. V. Myakova, V. P. Nazhimov, E. V. Skorobogatova, L. N. Shelikhova, I. P. Shipitsina, P. E. Trakhtman, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 29-38 (2022)
Early complications of hematopoietic stem cell transplantation (HSCT) of vascular origin within the first 30-60 days after HSCT, which are resulting from endothelial injury, are an important cause of transplant-associated morbidity and mortality. Aut
Externí odkaz:
https://doaj.org/article/888b9597ef2e4a1fb703facfe3df5490
Autor:
T. V. Shamanskaya, S. R. Varfolomeeva, D. Yu. Kachanov, R. A. Moiseenko, M. V. Teleshova, D. M. Konovalov, V. Yu. Roshchin, A. N. Kazakova, L. V. Zemtsova, A. E. Drui, M. Ya. Yadgarov, G. V. Tereshchenko, A. P. Shcherbakov, Yu. N. Likar, M. N. Sukhov, N. S. Grachev, D. G. Akhaladze, M. A. Maschan, A. V. Nechesnyuk, A. V. Pshonkin, E. E. Kurnikova, E. V. Skorobogatova, L. A. Khachatryan, D. K. Fomin, A. A. Maschan, A. G. Rumyantsev, G. A. Novichkova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:65-91
Treatment of patients with high-risk neuroblastoma (NB) is a complex challenge, and it is based on response to certain elements of therapy. The development and introduction of new treatment approaches, such as GD2-targeted immunotherapy (IT), leads t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e492e09647cb76f8202913086732e783
https://doi.org/10.24287/1726-1708-2023-22-2-65-91
https://doi.org/10.24287/1726-1708-2023-22-2-65-91
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:159-165
Extracorporeal photopheresis is a method of cell therapy that was developed and introduced into clinical practice of various specialties over 30 years ago but its mechanism of action, clinical application and the possibility of further modification a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f91664f7f0e509e79d79db75fb479cf5
https://doi.org/10.24287/1726-1708-2023-22-2-159-165
https://doi.org/10.24287/1726-1708-2023-22-2-159-165
Autor:
L. A. Vavilova, Yu. Yu. Dyakonova, O. I. Bydanov, N. V. Myakova, Yu. G. Abugova, L. Kh. Anderzhanova, D. A. Evstratov, E. E. Kurnikova, A. M. Popov, Yu. V. Olshanskaya, M. A. Maschan, L. N. Shelikhova, D. V. Litvinov, A. V. Popa, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:62-72
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Despite remarkable improvements in the treatment of pediatric acute lymphoblastic leukemia over last years, relapse still carries a poor prognosis with considerable morbidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ed935a04ba533aa4121b7f0900658cc
https://doi.org/10.24287/1726-1708-2023-22-1-62-72
https://doi.org/10.24287/1726-1708-2023-22-1-62-72
Autor:
D A SHASHELEVA, A A MASCHAN, L N SHELIKHOVA, U N PETROVA, E E KURNIKOVA, O I ILLARIONOVA, E V BOYAKOVA, G A NOVICHKOVA, M A MASCHAN
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 57-64 (2018)
The main goal is to optimize hematopoietic stem cell transplantation (HSCT) approach among adolescents and young adults with paroxysmal nocturnal hemoglobinuria (PNH) by means of Graft-versus-host disease (GVHD) and post-transplant complications risk
Externí odkaz:
https://doaj.org/article/c5aa744b838d4ea0acb3b3e7f77cb253
Autor:
E. L. Beliaeva, A. V. Koloskov, I. M. Gutkin, O. I. Philippova, E. V. Chernova, E. A. Kurnikova, G. B. Dorofeeva
Publikováno v:
Russian journal of hematology and transfusiology. 67:367-376
Introduction. The hemostasis system plays a key role in the pathogenesis of cardiovascular diseases.Aim — to evaluate changes in quantitative and qualitative characteristics of ADAMTS13 metalloprotease and von Willebrand factor an tigen (vWF:Ag) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52a5774a9cb363d51d05f988b0bfde3b
https://doi.org/10.35754/0234-5730-2022-67-3-367-376
https://doi.org/10.35754/0234-5730-2022-67-3-367-376
Autor:
M. E. Leontyeva, E. R. Sultanova, S. A. Radygina, Yu. V. Skvortsova, Ya. O. Muzalevskiy, E. E. Kurnikova, D. E. Pershin, M. A. Maschan, D. N. Balashov
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 21:112-117
The COVID-19 pandemic continues to be a major public health threat worldwide. The course of this disease in immunocompromised patients is significantly different from that in healthy subjects, which is associated with the impossibility of virus elimi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64387da006710ca94a063fb2260241cc
https://doi.org/10.24287/1726-1708-2022-21-2-112-117
https://doi.org/10.24287/1726-1708-2022-21-2-112-117
Autor:
D. N. Balashov, E. E. Kurnikova, M. A. Maschan, Yu. V. Skvortsov, L. N. Shelikhova, P. E. Trakhtman, E. V. Boyakova, E. V. Skorobogatova, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 9, Iss 4, Pp 24-27 (2015)
Unsuccessful mobilization of hematopoietic stem cells (HSCs) before apheresis in allograft donor is a factor adversely affecting the characteristics of the obtained cell product and, as a consequence, the therapy outcome. This study investigates the
Externí odkaz:
https://doaj.org/article/ec3d1750346445c9ab989905d94a64a9
Autor:
M. A. Maschan, L. A. Khachatryan, Yu. V. Skvortsova, E. E. Kurnikova, D. A. Shasheleva, V. O. Bobrynina, D. N. Balashov, E. V. Skorobogatova, D. D. Baydildina, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 45-55 (2014)
Allogeneic hematopoietic stem cell transplantation (HSCT) is the standard curative therapy for juvenile myelomonocytic leukemia (JMML). Seventeen patients with JMML received myeloablative conditioning (busulfan-based — 15, treosulfan-based — 2).
Externí odkaz:
https://doaj.org/article/6e4f8b1ded44412bbefc3903bad71016